Tarsus Pharmaceuticals Inc. (TARS)
NASDAQ · Healthcare
Tarsus Pharmaceuticals Inc. Balance Sheet 2020–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total Assets | 562.2M | 377.0M | 265.5M | 227.9M | 178.9M | 172.0M |
| Cash & Equivalents | 183.6M | 94.8M | 224.9M | 71.7M | 171.3M | 168.1M |
| Liabilities | ||||||
| Total Liabilities | 218.7M | 152.5M | 68.5M | 35.0M | 12.2M | 6.0M |
| Long-Term Debt | 72.4M | 71.8M | 29.8M | 19.4M | 0 | — |
| Equity | ||||||
| Shareholders' Equity | 343.4M | 224.5M | 197.0M | 192.9M | 166.7M | 166.0M |
Tarsus Pharmaceuticals Inc. Balance Sheet — FAQ
Tarsus Pharmaceuticals Inc. (TARS) balance sheet over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see TARS's balance sheet history?
The chart and table above show Tarsus Pharmaceuticals Inc.'s balance sheet by year and by quarter, including the growth rate.